***Live: Tuesday, January 19, 2021, at 11am EST | 8am PST | 4pm GMT | 5pm CET ***Join this webcast to learn best practices to ensure a smooth transition from Phase 1 to Phase 2 studies, how a clinical supply provider can enable this process, as well as the role that integrated solutions can play***On demand available after final airing until Jan. 19, 2022***
*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021
**Thursday, October 29, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET***An increasing number of new chemical entities (NCEs) present with bioavailability issues. Low bioavailability is associated with increased pharmacokinetic variability in both preclinical species and humans, which can lead to additional development challenges. An expert will discuss API-sparing development techniques and innovative scalable drug delivery technologies that are proven to improve solubility and enhance bioavailability using a minimal amount of API. ***On demand available after final airing until Oct. 29, 2021***
*** Live: Monday, Oct. 26, 2020, 11am EDT| 8am PDT| 3pm GMT| 4pm CET *** What are typical challenges sponsors encounter during Phase 3 clinical trials? How can advance preparation during Phase 2 help mitigate risks? Learn effective strategies to avoid surprises and problems in late-stage trials from experience clinical trial and supply experts. ***On demand available after final airing until Oct. 26, 2021***
Review how data-driven approaches, including physiologically based pharmacokinetic (PBPK) modeling, parallel formulation screening, API sparing techniques, and optimal early dosing strategies can help avoid development pitfalls for small-molecule drug candidates on the path to clinic. Live: Wednesday, Sept. 23, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST On demand available after final airing until Sept. 23, 2021
Gain insight from Nicholas Hall, the Consumer Healthcare Products Association, and Catalent into the performance of the OTC market, some of the innovation trends and opportunities that are emerging, and the impact of OTC monograph reform on future developments. Live: Tuesday, May 5, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until May 5, 2021 Register free
Drug formulators are often tasked with trying to increase the bioavailability of poorly water-soluble drugs. This Pharmaceutical Technology eBook takes an in-depth look at one approach: Spray Drying for Bioavailability Enhancement.
Complex liquids can be problematic for scale-up and manufacture. Learn how the experts at Catalent have found solutions for the most challenging liquid formulations. Live: Tuesday, Mar. 17, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until Mar. 17, 2021 Register free
How can you overcome clinical import and export challenges within the Asia-Pacific region? Join Catalent’s Julie Delaney and Rognvald Lamb as they present the advantages of using Singapore as an APAC clinical supply hub. Live: US & Europe Broadcast: Wednesday, Feb. 19, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET Asia-Pacific Broadcast: Thursday, Feb. 20, 2020 at 8:30am IST | 11am CST | 12pm JST On demand available after airing until Feb. 19, 2021 Register free
With global development and manufacturing sites, Catalent combines its formulation and bioavailability enhancement experience, along with delivery technologies to support the launch of more than 100 new products every year.
Catalent’s site in Anagni, Italy offers extensive capabilities in aseptic liquid and powder filling, as well as comprehensive packaging solutions to support product launches for oral solids, sterile, and biologics products.
The application of a phase-appropriate quality-by-design (QbD) framework increases the understanding of the interplay between the process parameters of spray drying and product quality that, when applied during scale-up, increases the chances of a successful outcome of the commercial manufacturing process. Live: Tuesday, November 19, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET On demand available after airing until Nov. 19, 2020 Register free
Join this webcast to learn how to avoid common pitfalls in the tech transfer and scale-up process using an integrated approach. Live: Thursday, Oct. 24, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Oct. 24, 2020 Register free
Join experts for a discussion on how contracting with a single service provider can offer significant benefits to the customer. Live: Tuesday, Sept. 24, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Sept. 24, 2020 Register free
This webcast will describe one solution: Working with a clinical supply partner to handle the packaging and potential complex distribution logistics for expanded access programs and commercial supply. Live: Thursday, Sept. 19, 2019 10am EDT | 9am CDT | 3pm BST | 4pm CEST On demand available after airing until Sept. 19, 2020 Register free
With global development and manufacturing sites, Catalent combines its formulation and bioavailability enhancement experience, along with delivery technologies to support the launch of more than 100 new products every year.
Catalent offers its partners a wide range of innovative oral dose technologies that can benefit drug developers, and help to improve convenience and patient compliance, while reducing pill burden, which is especially important for vulnerable patient populations.
Catalent Pharma Solutions offers its partners end-to-end solutions, from early drug product development, formulation and drug delivery technologies, to manufacturing and global clinical supply services.
To match the growing demand for biopharmaceutical development and manufacturing, Catalent Biologics has invested extensively in its network to create a comprehensive end-to-end offering for its customers.